PL3851441T3 - Proces otrzymywania (S)-2-((2-((S)-4-(difluorometylo)-2-oksooksazolidyn-3-ylo)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oksazepin-9-ylo)amino)propanamidu - Google Patents

Proces otrzymywania (S)-2-((2-((S)-4-(difluorometylo)-2-oksooksazolidyn-3-ylo)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oksazepin-9-ylo)amino)propanamidu

Info

Publication number
PL3851441T3
PL3851441T3 PL20209166.6T PL20209166T PL3851441T3 PL 3851441 T3 PL3851441 T3 PL 3851441T3 PL 20209166 T PL20209166 T PL 20209166T PL 3851441 T3 PL3851441 T3 PL 3851441T3
Authority
PL
Poland
Prior art keywords
oxooxazolidin
oxazepin
dihydrobenzo
propanamide
imidazo
Prior art date
Application number
PL20209166.6T
Other languages
English (en)
Inventor
Francis Gosselin
Chong Han
Theresa CRAVILLION
Sean M. Kelly
Scott Savage
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL3851441T3 publication Critical patent/PL3851441T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL20209166.6T 2016-12-15 2017-12-15 Proces otrzymywania (S)-2-((2-((S)-4-(difluorometylo)-2-oksooksazolidyn-3-ylo)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oksazepin-9-ylo)amino)propanamidu PL3851441T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662434836P 2016-12-15 2016-12-15

Publications (1)

Publication Number Publication Date
PL3851441T3 true PL3851441T3 (pl) 2023-11-06

Family

ID=61027659

Family Applications (2)

Application Number Title Priority Date Filing Date
PL20209166.6T PL3851441T3 (pl) 2016-12-15 2017-12-15 Proces otrzymywania (S)-2-((2-((S)-4-(difluorometylo)-2-oksooksazolidyn-3-ylo)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oksazepin-9-ylo)amino)propanamidu
PL17835634T PL3555107T3 (pl) 2016-12-15 2017-12-15 Sposób wytwarzania (S)-2-((2-((S)-4-(difluorometylo)-2-oksooksazolidyn-3-ylo)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oksazepin-9-ylo)amino)propanamidu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17835634T PL3555107T3 (pl) 2016-12-15 2017-12-15 Sposób wytwarzania (S)-2-((2-((S)-4-(difluorometylo)-2-oksooksazolidyn-3-ylo)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oksazepin-9-ylo)amino)propanamidu

Country Status (17)

Country Link
US (1) US10781219B2 (pl)
EP (2) EP3851441B1 (pl)
JP (1) JP7004720B2 (pl)
KR (1) KR102537048B1 (pl)
CN (1) CN110088111B (pl)
AR (1) AR110527A1 (pl)
AU (2) AU2017378188B2 (pl)
ES (2) ES2953833T3 (pl)
HR (2) HRP20210592T1 (pl)
HU (1) HUE062517T2 (pl)
IL (2) IL267265B (pl)
MX (2) MX377921B (pl)
PL (2) PL3851441T3 (pl)
SG (1) SG10201913961PA (pl)
SI (1) SI3555107T1 (pl)
TW (1) TWI770093B (pl)
WO (1) WO2018109204A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111909173B (zh) 2015-07-02 2025-03-04 豪夫迈·罗氏有限公司 苯并氧氮杂䓬噁唑烷酮化合物及其使用方法
IL298518B2 (en) * 2017-04-28 2025-05-01 Hoffmann La Roche Polymorphs and solid forms of (S)–2–((2–((S–4–(difluoromethyl)–2–oxoxazolidin-3–yl)–5,6–dihydrobenzo[F]imidazo[1,2–D][1,4]oxazepin-9–yl)amino)propanamide and methods of preparation
WO2021041348A1 (en) 2019-08-26 2021-03-04 Arvinas Operations, Inc. Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
CN113227101B (zh) * 2019-11-25 2024-10-11 上海翰森生物医药科技有限公司 含三并环类衍生物的盐或晶型及其药物组合物
CA3166087C (en) * 2020-03-03 2025-05-13 Momentive Performance Materials Inc. CATALYST COMPOSITION
KR20240013791A (ko) * 2021-05-28 2024-01-30 제넨테크, 인크. 벤족사제핀 옥사졸리디논 화합물을 제조하기 위한 공정
TW202440096A (zh) 2023-03-24 2024-10-16 美商亞文納營運公司 雌激素受體降解劑之給藥方案
TW202517655A (zh) * 2023-07-14 2025-05-01 瑞士商赫孚孟拉羅股份公司 使用［Ｃｕ（μ－ｓａｌｂｅｎ）］錯合物之Ｃ－Ｎ偶合方法
KR20260049827A (ko) 2023-08-11 2026-04-14 에프. 호프만-라 로슈 아게 코팅 정제를 포함하는 약학적 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI423980B (zh) 2009-09-28 2014-01-21 Hoffmann La Roche 苯并氧氮呯ｐｉ３ｋ抑制劑化合物及使用方法
KR20140032383A (ko) * 2011-03-21 2014-03-14 에프. 호프만-라 로슈 아게 Pi3k p110 델타에 대하여 선택적인 벤즈옥사제핀 화합물 및 이의 사용 방법
US9303043B2 (en) 2013-03-13 2016-04-05 Greentech, Inc. Process for making benzoxazepin compounds
CN111909173B (zh) * 2015-07-02 2025-03-04 豪夫迈·罗氏有限公司 苯并氧氮杂䓬噁唑烷酮化合物及其使用方法
IL298518B2 (en) 2017-04-28 2025-05-01 Hoffmann La Roche Polymorphs and solid forms of (S)–2–((2–((S–4–(difluoromethyl)–2–oxoxazolidin-3–yl)–5,6–dihydrobenzo[F]imidazo[1,2–D][1,4]oxazepin-9–yl)amino)propanamide and methods of preparation

Also Published As

Publication number Publication date
MX2020010948A (es) 2021-01-08
IL267265B (en) 2021-03-25
CN110088111A (zh) 2019-08-02
SI3555107T1 (sl) 2021-07-30
EP3851441B1 (en) 2023-06-28
AU2017378188B2 (en) 2020-11-26
US10781219B2 (en) 2020-09-22
BR112019010481A2 (pt) 2019-09-10
PL3555107T3 (pl) 2021-07-05
JP2020502143A (ja) 2020-01-23
HUE062517T2 (hu) 2023-11-28
AU2021201046A1 (en) 2021-03-11
EP3851441C0 (en) 2023-06-28
AR110527A1 (es) 2019-04-10
MX2019006958A (es) 2019-08-01
JP7004720B2 (ja) 2022-01-21
TW201837044A (zh) 2018-10-16
EP3555107B1 (en) 2021-02-17
US20190292201A1 (en) 2019-09-26
HRP20230948T1 (hr) 2023-11-24
IL281087A (en) 2021-04-29
KR102537048B1 (ko) 2023-05-26
EP3555107A1 (en) 2019-10-23
ES2867389T3 (es) 2021-10-20
CN110088111B (zh) 2021-08-03
IL267265A (en) 2019-08-29
HRP20210592T1 (hr) 2021-05-14
CA3044500A1 (en) 2018-06-21
SG10201913961PA (en) 2020-03-30
WO2018109204A1 (en) 2018-06-21
MX377921B (es) 2025-03-10
ES2953833T3 (es) 2023-11-16
KR20190093654A (ko) 2019-08-09
EP3851441A1 (en) 2021-07-21
AU2017378188A1 (en) 2019-05-30
TWI770093B (zh) 2022-07-11

Similar Documents

Publication Publication Date Title
IL281087A (en) Process for preparing (S)-2-((2-((S)-4-(difluoromethyl)-2-oxoxazolidine-3-YL)-6,5-dihydrobenzo[F]imidazo[2,1-D][4 , 1]oxazapine-9-YL)amino)propanamide
IL267464A (en) Polymorphs and solid forms of (s)-2-((2-((s-4-(difluoromethyl)-2-oxoxolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][ 1,4]oxazepin-9-yl)amino)propanamide and methods of production
IL266170A (en) A process for the preparation of pyrazolo[1,5-a]pyrimidines and their salts
IL288080A (en) A process for the preparation of h7-pyrrolo[3,2-d]pyrimidine derivatives and their artificial intermediates
IL276917A (en) A process for the preparation of alubixivet
SI3097098T1 (sl) Postopek za pripravo N-((3-aminooksetana-3-il)metil)-2-(1,1-diokso- 3,5-dihidro-1,4-benzotiazepin-4-il)-6-metil-kinazolin-4-amina
SG10202110927VA (en) Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid
PT3580219T (pt) Processo para a preparação de remimazolam e formas de estado sólido de sais de remimazolam
IL260999B (en) A method for the preparation of a pyrrolo[3,2-d] pyrimidine compound, and its intermediates
IL260465B (en) A process for preparing an antibody-rifamycin conjugate
HUE063118T2 (hu) Eljárás N-alkil-nitrátoetilnitraminok elõállítására
EP3405456A4 (en) PROCESS FOR THE PREPARATION OF 4-ALKOXY-3-ACETOXYPICOLINIC ACIDS
IL281254A (en) A process for the preparation of lanbatinib
IL248965A0 (en) Polymorphs of 2-(4-(2-(1-isopropyl-3-methyl-1h-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d] [1,4]oxazapine-9-yl)-2-methylpropanamide, preparation methods and their pharmaceutical uses
EP3422855A4 (en) PROCESS FOR THE PREPARATION OF 4-ALKOXY-3-HYDROXYPICOLIC ACIDS
EP3294703A4 (en) A process for the preparation of verapamil hydrochloride
HUE058725T2 (hu) Eljárás aminok elõállítására
AU2018297073A1 (en) Process for the preparation of morphinane compounds
HUP1800278A2 (en) Process for the preparation of boc-linagliptin
HUE053496T2 (hu) Eljárás izocianátok elõállítására
IL274560A (en) A process for the preparation of raltagravir
IL265013B (en) Process for the preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[3,2-b;3',4'-d]pyrrole
IL268103A (en) A process for the preparation of chiral pyrrolidine-2-yl-methanol derivatives
HUP1800397A2 (en) Process for the preparation of lumateperone and salts thereof